Literature DB >> 11841936

Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme.

Laurie A Witucki1, Xin Huang, Kavita Shah, Yi Liu, Saw Kyin, Michael J Eck, Kevan M Shokat.   

Abstract

The direct substrates of one protein kinase in a cell can be identified by mutation of the ATP binding pocket to allow an unnatural ATP analog to be accepted exclusively by the engineered kinase. Here, we present structural and functional assessment of peptide specificity of mutant protein kinases with unnatural ATP analogs. The crystal structure (2.8 A resolution) of c-Src (T338G) with N(6)-(benzyl) ADP bound shows that the creation of a unique nucleotide binding pocket does not alter the phospho-acceptor binding site of the kinase. A panel of optimal peptide substrates of defined sequence, as well as a degenerate peptide library, was utilized to assess the phospho-acceptor specificity of the engineered "traceable" kinases. The specificity profiles for the mutant kinases were found to be identical to those of their wild-type counterparts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841936     DOI: 10.1016/s1074-5521(02)00091-1

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  20 in total

Review 1.  Understanding and exploiting substrate recognition by protein kinases.

Authors:  Benjamin E Turk
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

Review 2.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

Review 3.  SH3 domains: modules of protein-protein interactions.

Authors:  Natalya Kurochkina; Udayan Guha
Journal:  Biophys Rev       Date:  2012-06-20

4.  Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.

Authors:  Kavita Shah; Fabien Vincent
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

5.  Analysis of substrates of protein kinase C isoforms in human breast cells by the traceable kinase method.

Authors:  Xiangyu Chen; Xin Zhao; Thushara P Abeyweera; Susan A Rotenberg
Journal:  Biochemistry       Date:  2012-08-29       Impact factor: 3.162

Review 6.  Recent advances in phosphoproteomics and application to neurological diseases.

Authors:  Justine V Arrington; Chuan-Chih Hsu; Sarah G Elder; W Andy Tao
Journal:  Analyst       Date:  2017-11-20       Impact factor: 4.616

7.  Mek1 kinase activity functions downstream of RED1 in the regulation of meiotic double strand break repair in budding yeast.

Authors:  Lihong Wan; Teresa de los Santos; Chao Zhang; Kevan Shokat; Nancy M Hollingsworth
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

8.  Cdk1 Controls Global Epigenetic Landscape in Embryonic Stem Cells.

Authors:  Wojciech Michowski; Joel M Chick; Chen Chu; Aleksandra Kolodziejczyk; Yichen Wang; Jan M Suski; Brian Abraham; Lars Anders; Daniel Day; Lukas M Dunkl; Mitchell Li Cheong Man; Tian Zhang; Phatthamon Laphanuwat; Nickolas A Bacon; Lijun Liu; Anne Fassl; Samanta Sharma; Tobias Otto; Emanuelle Jecrois; Richard Han; Katharine E Sweeney; Samuele Marro; Marius Wernig; Yan Geng; Alan Moses; Cheng Li; Steven P Gygi; Richard A Young; Piotr Sicinski
Journal:  Mol Cell       Date:  2020-04-01       Impact factor: 17.970

9.  Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.

Authors:  Thushara P Abeyweera; Xiangyu Chen; Susan A Rotenberg
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

10.  Targeting the cyclin-dependent kinase 5 in metastatic melanoma.

Authors:  Samanta Sharma; Tian Zhang; Wojciech Michowski; Vito W Rebecca; Min Xiao; Roberta Ferretti; Jan M Suski; Roderick T Bronson; Joao A Paulo; Dennie Frederick; Anne Fassl; Genevieve M Boland; Yan Geng; Jacqueline A Lees; Rene H Medema; Meenhard Herlyn; Steven P Gygi; Piotr Sicinski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.